Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Research progress of Fanconi anemia and DNA interstrand crosslink repair]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35381685 | PubTator, text mining | PubMed |
| Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro. | Front Cell Infect Microbiol | 2022 | 35372095 | PubTator, text mining | PubMed |
| Cell cycle regulation: p53-p21-RB signaling. | Cell Death Differ | 2022 | 35361964 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review. | Front Aging Neurosci | 2022 | 35360215 | PubTator, text mining | PubMed |
| Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. | Front Oncol | 2022 | 35359366 | PubTator, text mining | PubMed |
| Fate of Antibiotic Resistance Genes and Changes in Bacterial Community With Increasing Breeding Scale of Layer Manure. | Front Microbiol | 2022 | 35356511 | PubTator, text mining | PubMed |
| Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies. | Front Oncol | 2022 | 35356204 | PubTator, text mining | PubMed |
| Teledentistry awareness, its usefulness, and challenges among dental professionals in Pakistan and Saudi Arabia. | Digit Health | 2022 | 35355810 | PubTator, text mining | PubMed |
| Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy. | J Pers Med | 2022 | 35330396 | PubTator, text mining | PubMed |
| Roles of the Core Components of the Mammalian miRISC in Chromatin Biology. | Genes (Basel) | 2022 | 35327968 | PubTator, text mining | PubMed |
| Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions. | Cancers (Basel) | 2022 | 35326655 | PubTator, text mining | PubMed |
| PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth. | BMC Cancer | 2022 | 35321693 | PubTator, text mining | PubMed |
| Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group. | Curr Oncol Rep | 2022 | 35320498 | PubTator, text mining | PubMed |
| Estimated date of delivery with electronic medical records by a hybrid GBDT-GRU model. | Sci Rep | 2022 | 35318360 | PubTator, text mining | PubMed |
| Germline variants in genes of the subcortical maternal complex and Multilocus Imprinting Disturbance are associated with miscarriage/infertility or Beckwith-Wiedemann progeny. | Clin Epigenetics | 2022 | 35317853 | PubTator, text mining | PubMed |
| Synthesis, Purification, and Rotational Spectroscopy of 1-Cyanocyclobutene (C5H5N). | J Phys Chem A | 2022 | 35316046 | PubTator, text mining | PubMed |
| Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes. | Ther Adv Med Oncol | 2022 | 35309086 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Association of variations in the Fanconi anemia complementation group and prognosis in Non-small cell lung cancer patients with Platinum-based chemotherapy. | Gene | 2022 | 35306114 | PubTator, text mining | PubMed |
| ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study. | Clin Cancer Res | 2022 | 35302585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=29